BioRestorative Therapies, Inc.

Nasdaq:BRTX

Services-Misc Health & Allied Services, NEC·MELVILLE, NY

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-K/A	FY 2023	12/31/23	11/6/24	→
↓

Earnings Releases (8-K)

7 shown

Filed	Period
11/12/25	Q4 FY2025THIRD QUARTER 2025 FINANCIAL RESULTS	→
8/12/25	Q3 FY2025Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL	→
5/14/25	Q2 FY2025FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL	→
3/27/25	Q1 FY2025FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL	→
11/13/24	Q4 FY2024THIRD QUARTER RESULTS AND ORS PRESENTATION	→
8/13/24	Q3 FY2024SECOND QUARTER RESULTS	→
↓

News (8-K)

73 shown

Filed	Type	Description
2/17/26	Agreement	Entry into a Material Definitive Agreement	→
10/8/25	Agreement	Entry into a Material Definitive Agreement	→
9/25/25	Vote	ANNUAL MEETING VOTE	→
8/14/25	Reg FD	PRESENTATION MATERIALS	→
6/13/25	Reg FD	PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH	→
4/21/25	Other	CHANGE IN ACCOUNTANTS	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/13/26	424B4	424B4	→
2/10/26	S-1/A	S-1/A	→
2/9/26	S-1	S-1	→
12/12/25	424B3	PROSPECTUS RE 508,592 SHARES OF COMMON STOCK	→
11/18/25	S-8	S-8	→
11/18/25	S-1	S-1	→
↓

Filing History(723 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 23, 2026

0002027680-26-000001

—

6.3 KB

SCHEDULE 13G

Feb 18, 2026

0001213900-26-017939

—

16.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001700205-26-000003

—

79.3 KB

8-K

Feb 17, 2026

0001493152-26-0068378-K

Feb 11, 2026

353.7 KB

SCHEDULE 13G

Feb 13, 2026

0001896206-26-000003

—

6.9 KB

424B4

Feb 13, 2026

0001493152-26-006580424B4

—

2.5 MB

EFFECT

Feb 11, 2026

9999999995-26-000543

—

1.8 KB

S-1/A

Feb 10, 2026

0001493152-26-006012S-1/A

—

419.7 KB

S-1

Feb 9, 2026

0001493152-26-005827S-1

—

12.0 MB

DRS

Dec 19, 2025

0001493152-25-028561

—

450.9 KB

SCHEDULE 13G/A

Dec 19, 2025

0002027680-25-000006

—

6.5 KB

424B3

Dec 12, 2025

0001021771-25-000152PROSPECTUS RE 508,592 SHARES OF COMMON STOCK

—

164.1 KB

EFFECT

Dec 10, 2025

9999999995-25-003635

—

1.8 KB

S-8

Nov 18, 2025

0001493152-25-024082S-8

—

235.9 KB

S-1

Nov 18, 2025

0001493152-25-024081S-1

—

574.4 KB

10-Q

Nov 12, 2025

0001493152-25-02199310-Q

Sep 30, 2025

4.2 MB

8-K

Nov 12, 2025

0001021771-25-000148THIRD QUARTER 2025 FINANCIAL RESULTS

Nov 12, 2025

4.5 MB

Oct 20, 2025

0001021771-25-000141

Oct 6, 2025

17.3 KB

Oct 20, 2025

0001021771-25-000140

Oct 6, 2025

13.1 KB

Oct 9, 2025

0001021771-25-000134

—

11.0 KB

8-K

Oct 8, 2025

0001493152-25-0174468-K

Oct 6, 2025

633.7 KB

424B5

Oct 8, 2025

0001493152-25-017433424B5

—

409.9 KB

424B5

Oct 6, 2025

0001493152-25-017037424B5

—

18.4 KB

8-K

Sep 25, 2025

0001021771-25-000131ANNUAL MEETING VOTE

Sep 18, 2025

159.6 KB

8-K

Aug 14, 2025

0001021771-25-000116PRESENTATION MATERIALS

Aug 14, 2025

15.5 MB

25 filings shown

Filed	Form	Description
8/8/25	DEF 14A	DEF 14A	→
8/8/24	DEF 14A	ANNUAL MEETING PROXY STATEMENT	→
8/4/23	DEF 14A	2023 ANNUAL MEETING PROXY STATEMENT	→
9/23/22	DEF 14A	ANNUAL MEETING PROXY STATEMENT	→
8/5/22	PRE 14A	2022 ANNUAL MEETING PROXY STATEMENT	→
8/12/21	DEFA14A	DEFINITIVE ADDITIONAL PROXY MATERIALS	→
↓

BioRestorative Therapies, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(723 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/20/25	4	4	→
10/20/25	4	4	→
2/19/25	4	4	→
2/19/25	4	4	→
2/19/25	4	4	→
2/19/25	4	4	→
↓

Filed	Form	Description
2/23/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/18/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G	SCHEDULE 13G	→
2/11/26	EFFECT	EFFECT	→
12/19/25	DRS	DRS	→
↓